TABLE 3.
NGT (n = 763) | GDM‐IFH (n = 56) | GDM‐IPH (n = 70) | GDM‐CH (n = 43) | P‐value | |
---|---|---|---|---|---|
Induction of foetal lung maturation | 51 (6.6) | 2 (3.5) | 7 (10.0) | 2 (4.8) | .484 |
Caesarean section | 337 (43.8) | 28 (49.1) | 28 (39.4) | 21 (48.8) | .654 |
Vacuum extraction | 38 (5.0) | 3 (5.3) | 4 (5.6) | 0 (0.0) | .219 |
Neonatal intensive care unit | 40 (5.3) | 5 (8.8) | 4 (5.7) | 1 (2.4) | .574 |
GAD (wks) | 38.7 ± 1.8 | 38.6 ± 1.4 | 38.3 ± 1.6 | 38.4 ± 1.5 | .332 |
Preterm delivery (<37 wks) | 64 (8.3) | 3 (5.3) | 8 (11.3) | 4 (9.3) | .574 |
Birth weight (percentile) | 57 ± 28 | 64 ± 26 | 59 ± 30 | 56 ± 32 | .372 |
LGA | 108 (14.2) | 9 (16.1) | 13 (18.6) | 9 (20.9) | .529 |
Data are mean ± SD or median (IQR) and count (%) for women remaining normal glucose tolerant (NGT) vs patients developing gestational diabetes (GDM) with impaired fasting plasma glucose (IFH), impaired post‐load glucose (IPH) or both (CH).
Abbreviations: GAD, gestational age at delivery; LGA, large for gestational age offspring.